Murdoch Childrens Research Institute
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Holding
- Established
- 1986-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.mcri.edu.au
Clinical Trials
113
Active:12
Completed:58
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:9
Phase 2:14
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (103 trials with phase data)• Click on a phase to view related trials
Not Applicable
49 (47.6%)Phase 3
15 (14.6%)Phase 4
15 (14.6%)Phase 2
14 (13.6%)Phase 1
9 (8.7%)Early Phase 1
1 (1.0%)Using a Speech-Generating Device to Support Communication in Childhood Dementia
Not Applicable
Not yet recruiting
- Conditions
- Childhood DementiaGenetic DiseaseNonverbal CommunicationAugmentative and Alternative Communication
- First Posted Date
- 2025-06-26
- Last Posted Date
- 2025-06-26
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 38
- Registration Number
- NCT07039084
- Locations
- 🇦🇺
Murdoch Children's Research Institute, Melbourne, Victoria, Australia
Wearable Technology and Machine Learning for Early Detection and Risk Assessment of Unacceptable Toxicities in a Paediatric Oncology Cohort
Not yet recruiting
- Conditions
- CancerInfectionDigital HealthWearable Devices
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-07-02
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 150
- Registration Number
- NCT07030998
- Locations
- 🇦🇺
The Royal Children's Hospital, Parkville, Victoria, Australia
A Strep Throat Controlled Human Infection Trial in Healthy Adults
Early Phase 1
Not yet recruiting
- Conditions
- Streptococcus Pyogenes PharyngitisStreptococcus Infection
- Interventions
- Biological: Streptococcus pyogenes M1UK strain MCRI0102
- First Posted Date
- 2025-05-28
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06992141
- Locations
- 🇦🇺
Doherty Clinical Trials Ltd, Melbourne, Victoria, Australia
Jack Jumper Ant Venom Immunotherapy Long-term Effectiveness Investigation
Phase 4
Not yet recruiting
- Conditions
- AllergyImmunotherapyVenom Allergy
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 100
- Registration Number
- NCT06935890
- Locations
- 🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Royal Hobart Hospital, Hobart, Tasmania, Australia
🇦🇺Monash Medical Centre, Clayton, Victoria, Australia
HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation
Phase 1
Not yet recruiting
- Conditions
- Scabies
- Interventions
- Drug: ivermectin infant formula preparationDrug: Standard ivermectin 3mg tablet
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 52
- Registration Number
- NCT06918665
- Locations
- 🇦🇺
The Royal Children's Hospital, Melbourne, Victoria, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
News
No news found